Candel Therapeutics, Inc. (CADL) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$4.79
Day's range
$5.17

Candel Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 08/13/2026 10.99 M $113.20 M   0.03% 14.83%
RTW INVESTMENTS, LP 08/14/2026 6.42 M $66.15 M   0.00% 8.66%
BLACKROCK, INC. 08/07/2026 4.97 M $51.18 M   59.83% 6.70%
STATE STREET CORP 09/22/2026 3.55 M $36.56 M   333.67% 4.79%
ACORN CAPITAL ADVISORS, LLC 08/14/2026 3.50 M $36.03 M   0.00% 4.72%
PORTOLAN CAPITAL MANAGEMENT, LLC 08/14/2026 3.49 M $35.95 M   20.59% 4.71%
SATURN V CAPITAL MANAGEMENT LLC 08/14/2026 3.30 M $34.03 M   14.05% 4.46%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 2.69 M $27.75 M   9.39% 3.63%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 1.57 M $16.18 M   51.73% 2.12%
MILLENNIUM MANAGEMENT LLC 08/14/2026 1.09 M $11.27 M   3.19% 1.48%
HALTER FERGUSON FINANCIAL INC. 08/03/2026 772.46 K $7.96 M   -14.56% 1.04%
NORTHERN TRUST CORP 08/13/2026 492.47 K $5.07 M   52.39% 0.66%
KENNEDY CAPITAL MANAGEMENT LLC 08/14/2026 488.29 K $5.03 M   427.17% 0.66%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 437.15 K $4.50 M   62.96% 0.59%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 412.11 K $4.24 M   46.95% 0.56%
SANDS CAPITAL VENTURES, LLC 08/13/2026 405.84 K $4.18 M   0.00% 0.55%
GOLDMAN SACHS GROUP INC 08/14/2026 305.22 K $3.14 M   34.15% 0.41%
MARSHALL WACE, LLP 08/13/2026 300.64 K $3.10 M   100.00% 0.41%
ARETE WEALTH ADVISORS, LLC 08/11/2026 289.66 K $2.98 M   100.00% 0.39%
BANK OF AMERICA CORP /DE/ 08/14/2026 278.94 K $2.87 M   488.46% 0.38%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 227.94 K $2.35 M   101.76% 0.31%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 205.75 K $2.12 M   100.00% 0.28%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 199.45 K $2.05 M   78.54% 0.27%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 199.45 K $2.05 M   100.00% 0.27%
TANAGER WEALTH MANAGEMENT LLP 07/23/2026 198.18 K $2.04 M   0.00% 0.27%
BANK OF NEW YORK MELLON CORP 08/06/2026 191.70 K $1.97 M   40.68% 0.26%
UBS GROUP AG 08/13/2026 169.27 K $1.74 M   12.96% 0.23%
JANE STREET GROUP, LLC 08/14/2026 151.60 K $1.56 M   0.07% 0.20%
CITADEL ADVISORS LLC 09/02/2026 146.02 K $1.50 M   100.94% 0.20%
NUVEEN, LLC 08/11/2026 142.98 K $1.47 M   53.48% 0.19%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2026 129.18 K $1.33 M   20.49% 0.17%
MORGAN STANLEY 08/13/2026 126.15 K $1.30 M   116.64% 0.17%
COMMONWEALTH EQUITY SERVICES, LLC 07/29/2026 115.88 K $1.19 M   21.47% 0.16%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 114.10 K $1.18 M   -31.31% 0.15%
D. E. SHAW & CO., INC. 08/14/2026 108.93 K $1.12 M   100.00% 0.15%
JUMP FINANCIAL, LLC 08/13/2026 106.84 K $1.10 M   100.00% 0.14%
TREXQUANT INVESTMENT LP 08/14/2026 101.32 K $1.04 M   100.00% 0.14%
GHISALLO CAPITAL MANAGEMENT LLC 08/14/2026 100.00 K $1.03 M   -50.00% 0.13%
KYNAM CAPITAL MANAGEMENT, LP 08/14/2026 96.74 K $996.43 K   -51.63% 0.13%
CITIGROUP INC 08/03/2026 85.51 K $880.75 K   299.92% 0.12%
RHUMBLINE ADVISERS 08/12/2026 78.05 K $803.86 K   51.84% 0.11%
SQUAREPOINT OPS LLC 08/14/2026 75.21 K $774.67 K   100.00% 0.10%
ALPS ADVISORS INC 07/29/2026 74.36 K $765.94 K   24.71% 0.10%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 73.50 K $757.00 K   70.10% 0.10%
Y-INTERCEPT (HONG KONG) LTD 07/14/2026 68.47 K $705.26 K   100.00% 0.09%
HB WEALTH MANAGEMENT, LLC 07/29/2026 67.40 K $694.18 K   0.22% 0.09%
TORREY GROWTH & INCOME ADVISORS 07/27/2026 66.46 K $739.66 K   -1.03% 0.09%
CREATIVE PLANNING 08/13/2026 65.09 K $670.41 K   107.30% 0.09%
DEUTSCHE BANK AG\ 08/07/2026 62.94 K $648.29 K   89.01% 0.08%
CITADEL ADVISORS LLC 09/02/2026 61.80 K $636.54 K   100.00% 0.08%

Candel Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 165 institutional investors and hedge funds held shares of Candel Therapeutics Inc. The most heavily invested institutionals were:

FMR LLC: 10.99 M

RTW INVESTMENTS, LP: 6.42 M

BlackRock, Inc.: 4.97 M

STATE STREET CORP: 3.55 M

ACORN CAPITAL ADVISORS, LLC: 3.5 M

Portolan Capital Management, LLC: 3.49 M

68.64% of Candel Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 56.28 M shares in the last 24 months. This purchase volume represents approximately $288.70 M in transactions.